Rapporto sull’analisi delle dimensioni e delle quote del mercato dei vaccini a base vegetale | Previsioni 2031

  • Report Code : TIPRE00024327
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 243
Buy Now

[Rapporto di ricerca] Si prevede che il mercato dei vaccini a base vegetale raggiungerà 2.672,05 milioni di dollari entro il 2028 da 1.143,72 milioni di dollari nel 2021. Si stima che il mercato crescerà a un CAGR del 12,9% dal 2021 al 2028.

L'ambito del mercato dei vaccini a base vegetale comprende il tipo di vaccino, la fonte, l'applicazione e la geografia. In base alla regione, il mercato dei vaccini a base vegetale è segmentato in Nord America, Europa, Asia Pacifico, Medio Oriente e Asia. Africa e America meridionale e centrale. Il rapporto offre approfondimenti e analisi approfondite del mercato dei vaccini a base vegetale, sottolineando vari parametri quali tendenze e opportunità di mercato, dinamiche di mercato e analisi del panorama competitivo dei principali attori del mercato in Nord America, Europa, Asia Pacifico, Medio Oriente e Asia. ; Africa e America meridionale e centrale. Include anche l'analisi dell'impatto del COVID-19 nelle regioni.


Approfondimenti strategici

Regioni redditizie per il mercato dei vaccini a base vegetale


Approfondimenti di mercato

Numero crescente di ricerche e informazioni Attività di sviluppo (ricerca e sviluppo) di vaccini di origine vegetale

La mancanza di vaccini per prevenire malattie mortali ha creato problemi e ha spinto a concentrarsi a livello mondiale sullo sviluppo di vaccini più sicuri, più facili e più efficaci. Le piante sono tra i creatori di proteine più prolifici al mondo. Le piante esprimono in modo efficiente proteine di varia complessità e modelli di glicosilazione. La tecnologia ricombinante viene utilizzata per creare vaccini di origine vegetale, in cui il gene che codifica la proteina antigene richiesta è incorporato nel genoma della pianta. Inoltre, gli esperti stimano che la produzione di un vaccino a base vegetale richieda dalle cinque alle sei settimane invece dei cinque-sei mesi richiesti dai produttori di vaccini per preparare il vaccino nelle uova di gallina. Molti paesi in tutto il mondo stanno sviluppando un vaccino efficace per combattere la diffusione del COVID-19 e i vaccini di origine vegetale sono una delle opzioni per lo sviluppo di vaccini. I vaccini a base vegetale godono di una buona reputazione tra i ricercatori grazie alla loro ben nota procedura di produzione di successo e al basso costo. Vengono effettuate varie ricerche e sperimentazioni cliniche per lo sviluppo di vaccini a base vegetale. Ad esempio, Medicago Inc., un’azienda biotecnologica in fase clinica che utilizza tecnologie di origine vegetale per sviluppare e produrre nuovi vaccini e anticorpi, ha prodotto con successo particelle simili a virus (VLP) del nuovo coronavirus appena 20 giorni dopo aver ottenuto il virus SARS-CoV- 2 (il virus che causa la malattia COVID-19). Gli attori di spicco esistenti e i nuovi entranti nel mercato dei vaccini a base vegetale stanno concentrando i loro sforzi sulla conduzione di studi clinici completi per produrre vaccini a base vegetale per una varietà di applicazioni terapeutiche. Pertanto, il numero crescente di attività di ricerca e di ricerca Le attività di sviluppo (R&S) di vaccini di origine vegetale aumenteranno notevolmente la domanda di vaccini di origine vegetale in tutto il mondo, determinando una spinta al rialzo nella crescita del mercato.

< h3>Approfondimenti basati sul tipo di vaccino

In base al tipo di vaccino, il mercato dei vaccini a base vegetale è segmentato in vaccini batterici, vaccini virali, vaccini antiparassitari, particelle simili a virus di origine vegetale (VLPS) e altri . Il segmento dei vaccini batterici ha detenuto la quota maggiore del mercato nel 2021. Tuttavia, si prevede che il segmento delle particelle simili a virus di origine vegetale (VLP) registrerà il CAGR più elevato del 13,6% nel mercato durante il periodo di previsione.

Mercato dei vaccini di origine vegetale, per tipo di vaccino - 2021 e 2028


Approfondimenti basati sulla fonte

Basati sulla fonte, il mercato dei vaccini a base vegetale è segmentato in pianta del tabacco, mais, patate e altri. Il segmento delle piante di tabacco ha detenuto la quota maggiore del mercato nel 2021 e si prevede che lo stesso segmento registrerà il CAGR più elevato del 13,3% nel mercato durante il periodo di previsione.

< h3>Approfondimenti basati sull'applicazione

In base all'applicazione, il mercato dei vaccini a base vegetale è segmentato in influenza, virus Zika, virus Ebola, malattie del pollame, COVID-19 e altri. Il segmento dell'influenza ha detenuto la quota maggiore del mercato nel 2021. Tuttavia, si prevede che il segmento COVID-19 registrerà il CAGR più elevato del 13,8% nel mercato durante il periodo di previsione.

Le aziende adottano comunemente strategie inorganiche come fusioni e acquisizioni per soddisfare le mutevoli richieste dei clienti e mantenere il proprio marchio in tutto il mondo. Gli operatori di mercato che operano nel mercato dei vaccini a base vegetale adottano anche strategie organiche come il lancio e l'espansione dei prodotti per estendere la propria presenza e il portafoglio di prodotti in tutto il mondo e soddisfare la crescente domanda.

Per tipo di vaccino

  • Vaccini batterici
  • Vaccini virali
  • Vaccini parassiti
  • Particelle virali di origine vegetale (VLP)
  • Altro

Per fonte

  • Pianta di tabacco
  • Mais
  • Patata
  • Altro

Per applicazione

  • Influenza< /li>
  • Virus Zika
  • Virus Ebola
  • COVID-19
  • Malattia del pollame
  • Altro
  • Per geografia

    • Nord America
      • Stati Uniti
      • Canada
      • Messico
    • Europa
      • Regno Unito
      • Germania
      • Francia
      • Italia
      • Spagna
      • Resto d'Europa
    • Asia Pacifico
      • Cina
      • Giappone
      • India
      • Australia
      • Corea del Sud
      • Resto dell'Asia Pacifico
    • Medio Est e; Africa
      • Arabia Saudita
      • Sudafrica
      • Emirati Arabi Uniti
      • Resto del Medio Oriente e dell'Africa Africa
    • America meridionale e centrale
      • Brasile
      • Argentina
      • Resto dell'America meridionale e centrale

    Profili aziendali

    • MEDICAGO, INC.
    • Britannico American Tobacco plc
    • ICON GENETICS GMBH
    • CREATIVE BIOLABS, Inc. & Nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp;
    • iBio, Inc.
    • LENIOBIO
    • Lumen Bioscience, Inc.
    • LEAF EXPRESSION SYSTEMS LTD.
    • ZYUS LIFE SCIENCES INC.
    • FRAUNHOFER CMB
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which source is expected to dominate the market in the forecast period in Plant-Based Vaccines market?

The market is led by source tobacco plant segment is growing significantly due to the increasing use of tobacco plants in pharmaceuticals. The growing research in pharmaceutical is playing a vital role in developing new vaccines. For instance the U.S Department of Agriculture approved a plant-based vaccine for Newcastle disease that infected poultry and produced it in suspension-cultured tobacco cells.

What will be the CAGR of Plant-Based Vaccines market?

The market is estimated to grow with a CAGR of 12.9% from 2021 to 2028.

What are the driving factors for the Plant-based Vaccines market across the globe?

Key factors that are driving growth of the market are increasing number of research & development (R&D) activities in plant-based vaccines and growing prevalence of infectious diseases market fuel the growth of the market.

What are Plant-Based Vaccines?

Plant-based vaccines can be made cheaply and produced on a large scale. These vaccines have several advantages, including being readily accepted by patients and stable for long-term antigen storage. These also help to reduce the economic burden of infectious disease globally. Various plants have developed plant-derived vaccines such as potato, rice, maize, tomato, carrot, tobacco, soybean, and peanut. The choice of the plant depends on the route of administration of the vaccine.

The List of Companies - Plant-based Vaccines Market

  1. MEDICAGO, INC.
  2. British American Tobacco p.l.c.          
  3. ICON GENETICS GMBH
  4. CREATIVE BIOLABS, INC.      
  5. iBio, Inc.
  6. LENIOBIO
  7. Lumen Bioscience, Inc.
  8. LEAF EXPRESSION SYSTEMS LTD.
  9. ZYUS LIFE SCIENCES INC.
  10. FRAUNHOFER CMB

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports